Neuland Laboratories Debt/Equity
What is the Debt/Equity of Neuland Laboratories?
The Debt/Equity of Neuland Laboratories Limited is 0.73
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on BSE compared to Neuland Laboratories
What does Neuland Laboratories do?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Companies with debt/equity similar to Neuland Laboratories
- Kinross Gold has Debt/Equity of 0.73
- Akme Star Housing Finance has Debt/Equity of 0.73
- Premier Inc has Debt/Equity of 0.73
- Helen of Troy Ltd has Debt/Equity of 0.73
- Skillcast plc has Debt/Equity of 0.73
- Irish Residential Properties REIT Plc has Debt/Equity of 0.73
- Neuland Laboratories has Debt/Equity of 0.73
- RevoluGROUP Canada has Debt/Equity of 0.73
- Nanjing Wondux Environmental Protection Technology has Debt/Equity of 0.73
- Century Communities Inc has Debt/Equity of 0.73
- Culp has Debt/Equity of 0.73
- Steel City Securities has Debt/Equity of 0.73
- Acadia Pharmaceuticals Inc has Debt/Equity of 0.73